-
What Will The Psychedelics Space Look Like In 2021? Experts Weigh In
Monday, January 18, 2021 - 12:43pm | 1182In 2020, psychedelics took the world by storm. Over two dozen companies in the sector became publicly listed. The industry grew closer to federal legalization of the first psychedelic compounds for therapeutic use. With scientific, regulatory and corporate developments becoming...
-
Psyched: Numinus, MAPS To Spearhead MDMA Trials; Vancouver Plans To Decriminalize Drugs
Sunday, December 6, 2020 - 12:52pm | 844Numinus and MAPS Collaborate to Study MDMA in Canada Numinus Wellness (TSXV: NUMI) and the MAPS Public Benefit Corporation have joined forces to bring MDMA-assisted psychotherapy through clinical trials for approval in Canada. The pair will first seek permission to perform a single-arm, open-label...
-
Understanding The Psilocybin Supply Chain: Every Production Method Explained
Wednesday, December 2, 2020 - 9:57am | 1782Psilocybin is known as the active compound in so-called “magic mushrooms”, yet most psilocybin used in clinical trials today is synthesized in laboratories without the use of biological material. As psychedelics-assisted therapy gains momentum, investors need to understand the...